|
May 23, 2012
|
| 07:03 EDT |  | BRKR |
| theflyonthewall.com: | Bruker awarded $25M contract from Russia's Rosatom | | Bruker announced a large-scale technology transfer contract for its Bruker HTS GmbH subsidiary to license and transfer know-how for second generation YBCO ceramic tape high temperature superconductors to a subsidiary of the Russian state atomic energy corporation, Rosatom. The total contract value exceeds $25M, and BEST revenue is expected in various increments and milestones over an approximately two-year period, with expected deliveries commencing in 2013. :theflyonthewall.com |
|
|
May 22, 2012
|
| 10:26 EDT |  | SIRO |
|
| 08:33 EDT | | ARAY |
|
| 07:45 EDT |  | GHDX |
| theflyonthewall.com: | Genomic Health target raised to $43 from $33 at JMP Securities | | After conducting due diligence with oncology surgeons, JMP Securities believes that Genomic's DCIS test could potentially generate a large amount of revenue. The firm reiterates an Outperform rating. :theflyonthewall.com |
|
| 07:35 EDT |  | GPRO |
|
|
May 21, 2012
|
| 16:06 EDT | | MYGN |
| theflyonthewall.com: | Myriad Genetics and Intermountain Healthcare enter research agreement | | Intermountain Healthcare and Myriad Genetics (MYGN) announced they have signed a collaborative research agreement. The purpose of this agreement is to perform research and validation studies on transformative molecular diagnostic tests being developed by Myriad in an effort to improve the care and treatments for patients at Intermountain and around the world. This collaboration highlights the shared purpose of Myriad and Intermountain in improving outcomes and the quality of life for patients. The first project under this collaboration, PRO 008, is designed to further expand the utility of the Prolaris test by analyzing biopsy samples of 200 patients diagnosed with prostate cancer. This study will assess the ability of the Prolaris test to predict which men are at a heightened risk of biochemical recurrence and therefore should be given more aggressive therapy for their disease. The goal of this, and Myriad's other Prolaris studies underway in multiple centers in the United States and Europe, is to demonstrate the prognostic ability of the Prolaris test in assessing a patient's risk of biochemical recurrence of disease and death from disease. :theflyonthewall.com |
|
| 16:06 EDT | | SIRO |
|
| 11:23 EDT | | TMO |
|
| 10:34 EDT |  | WAT |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: Alpha Natural (ANR) upgraded to Buy from Hold at Brean Murray... American Eagle (AEO) upgraded to Buy from Hold at Brean Murray... Group 1 Automotive (GPI) upgraded to Buy from Neutral at Sterne Agee... LPL Investment (LPLA) upgraded to Neutral from Negative at Susquehanna... Mid-Con Energy (MCEP) upgraded to Outperform from Market Perform at Raymond James... Safeway (SWY) upgraded to Buy from Neutral at Citigroup... United Bankshares (UBSI) upgraded to Buy from Neutral at Janney Capital... Waters (WAT) upgraded to Buy from Neutral at Mizuho... Boeing (BA) upgraded to Buy from Hold at Argus. :theflyonthewall.com |
|
| 07:38 EDT | | MYGN |
|
| 07:30 EDT | | MYGN |
|
| 07:25 EDT | | LIFE |
| theflyonthewall.com: | Life Technologies shares undervalued, says Oppenheimer | | After meeting with Life's management, Oppenheimer believes that investors' concerns that the company will abandon its share buyback plans are unwarranted. The firm reiterates a $58 target and Outperform rating on the stock. :theflyonthewall.com |
|
| 05:34 EDT | | WAT |
|
|
May 18, 2012
|
| 09:34 EDT | | WX |
|
| 08:14 EDT | | HOLX, ISRG |
|
|
May 17, 2012
|
| 10:33 EDT | | WAT, TMO, BRKR, A |
| theflyonthewall.com: | On The Fly: Analyst Initiation Summary | | Today's noteworthy initiations include: Agilent (A) initiated with an Outperform at Wells Fargo... Alphatec (ATEC) initiated with an Overweight at Piper Jaffray... ArthroCare (ARTC) initiated with an Overweight at Piper Jaffray... Bruker (BRKR) initiated with an Outperform at Wells Fargo... CareFusion (CFN) initiated with an Overweight at Piper Jaffray... Celadon Group (CGI) initiated with a Buy at Wunderlich... Crocs (CROX) initiated with a Neutral at SunTrust... Infoblox (BLOX) initiated with an Outperform at JMP Securities... Kirby (KEX) initiated with a Buy at Wunderlich... Knight Transportation (KNX) initiated with a Buy at Wunderlich... Micron (MU) initiated with a Neutral at Susquehanna... Rush Enterprises (RUSHA) initiated with a Buy at Wunderlich... SanDisk (SNDK) initiated with a Positive at Susquehanna... Swift Transportation (SWFT) initiated with a Buy at Wunderlich... Thermo Fisher (TMO) initiated with a Market Perform at Wells Fargo... Tyler Technologies (TYL) initiated with a Buy at Benchmark Co... Waters (WAT) initiated with an Outperform at Wells Fargo... Werner (WERN) initiated with a Buy at Wunderlich... US Airways (LCC) initiated with an Outperform at Raymond James. :theflyonthewall.com |
|
| 09:36 EDT | | VAR |
| theflyonthewall.com: | Varian Medical management to meet with Lazard Capital | | Meeting to be held in Boston on May 18 hosted by Lazard Capital. :theflyonthewall.com |
|
| 09:35 EDT | | MTD |
|
| 09:00 EDT |  | A |
| theflyonthewall.com: | Agilent rises 5.6% | | Agilent is up 5.6%, or $2.24, to $42.00 :theflyonthewall.com |
|
| 07:04 EDT | | A |
|
| 06:58 EDT | | A |
|
| 06:45 EDT | | BRKR |
|
| 06:44 EDT | | TMO |
| theflyonthewall.com: | Thermo Fisher initiated with a Market Perform at Wells Fargo | | Price target range $55-$60. :theflyonthewall.com |
|
| 06:44 EDT | | A |
|
| 06:43 EDT | | WAT |
| theflyonthewall.com: | Waters initiated with an Outperform at Wells Fargo | | Price target range $98-$103. :theflyonthewall.com |
|
| 06:07 EDT |  | SHP |
|
| 06:06 EDT | | SHP |
| theflyonthewall.com: | ShangPharma reports Q1 adjusted EPS 17c, consensus 19c | | Reports Q1 revenue $30.8M, consensus $29.79M. :theflyonthewall.com |
|
|
May 16, 2012
|
| 09:47 EDT | | VAR |
|
|
May 15, 2012
|
| 10:14 EDT |  | TMO, LIFE |
|
| 09:41 EDT | | A |
|
| 08:00 EDT | | A |
|
| 07:52 EDT | | A |
| theflyonthewall.com: | Agilent price target raised to $57 from $50 at Lazard Capital | | Lazard Capital raised its price target for Agilent shares following the company's Q2 results and maintains a Buy rating on the stock. :theflyonthewall.com |
|
| 06:25 EDT | | TMO |
| theflyonthewall.com: | Thermo Fisher downgraded to Neutral from Buy at Mizuho | | Mizuho downgraded Life Technologies (LIFE) and Thermo Fisher (TMO) citing uncertainty surrounding academic spending. :theflyonthewall.com |
|
| 06:25 EDT | | LIFE |
|
|
May 14, 2012
|
| 18:04 EDT | | A |
|
| 18:01 EDT | | A |
|
| 16:13 EDT | | A |
|
| 16:11 EDT | | A |
|
| 14:57 EDT | | A |
| theflyonthewall.com: | Companies reporting After the Market Close on Monday, May 14 | | Notable companies reporting after the closing bell on Monday include Agilent (A) and Groupon (GRPN). :theflyonthewall.com |
|
| 09:08 EDT | | HOLX, GPRO |
|
| 07:01 EDT | | BRKR |
|
| 07:01 EDT | | HOLX |
| theflyonthewall.com: | Hologic upgraded to Overweight from Neutral at JPMorgan | | JP Morgan upgraded Holgic (HOLX) to reflect compelling risk/reward and synergies from the Gen-Probe (GPRO) deal. Price target raised to $22 from $20. :theflyonthewall.com |
|
|
May 11, 2012
|
| 22:06 EDT | | GHDX |
|
| 12:00 EDT | | WX |
|
| 09:33 EDT | | WAT |
|
| 09:19 EDT | | MYGN |
|
| 08:42 EDT | | A |
|
| 06:11 EDT | | MYGN |
|
|
May 10, 2012
|
| 16:46 EDT | | WX |
|
| 16:43 EDT | | WX |
|
| 16:40 EDT | | WX |
|
|
May 9, 2012
|
| 07:37 EDT | | WX |
|
| 07:10 EDT | | BRKR |
| theflyonthewall.com: | Bruker subsidiary awarded $5.2M in contracts for accelerator modules | | Bruker Energy & Supercon Technologies (BRKR)'s majority-owned subsidiary RI Research Instruments GmbH has been awarded a contract with the South Korea-based Pohang Accelerator Laboratory for the supply of a 500 MHz superconducting accelerator module, as well as the award of another contract with the Diamond Light Source in Great Britain for a similar 500 MHz superconducting accelerator module. The value of both contracts together is approximately $5.2M. :theflyonthewall.com |
|
Subscribe for More Information